The quality of reporting of randomized controlled trials of traditional Chinese medicine: a survey of 13 randomly selected journals from mainland China

G Wang, B Mao, ZY Xiong, T Fan, XD Chen, L Wang… - Clinical …, 2007 - Elsevier
Background: The number of randomized controlled trials (RCTs) of traditional Chinese
medicine (TCM) is increasing. However, there have been few systematic assessments of the …

Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study

…, W Wang, T Wu, B Lu, SY Zhu, LT Qian… - Blood, The Journal …, 2015 - ashpublications.org
The optimal combination and sequence of radiotherapy (RT) and chemotherapy (CT) for
extranodal nasal-type natural killer/T-cell lymphoma (NKTCL) are not well-defined. The aim of …

Efficacy and safety of antifibrotic agents in the treatment of CTD-ILD and RA-ILD: A systematic review and meta-analysis

M Yang, YQ Wu, XM Liu, C Zhao, T Li, TQ Li… - Respiratory …, 2023 - Elsevier
Objective The clinical spectrum of connective tissue disease-associated interstitial lung disease
(CTD-ILD) and rheumatoid arthritis-associated interstitial lung disease (RA-ILD) ranges …

[HTML][HTML] Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era …

…, Y Wang, C Hu, X He, LL Zhang, G Wu, BL Qu, LT Qian… - Leukemia, 2021 - nature.com
Derived from our original nomogram study by using the risk variables from multivariable
analyses in the derivation cohort of 1383 patients with extranodal NK/T-cell lymphoma, nasal-…

Association of improved locoregional control with prolonged survival in early-stage extranodal nasal-type natural killer/T-cell lymphoma

…, JZ Cao, SM Lan, JX Wu, T Wu, SY Zhu, LT Qian… - JAMA …, 2017 - jamanetwork.com
Importance The long-term survival benefit for radiotherapy (RT) in early-stage extranodal
natural killer/T-cell lymphoma (NKTCL) is not known, and it is unclear whether improved …

First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG

…, X He, C Hu, LL Zhang, G Wu, BL Qu, LT Qian… - Blood …, 2020 - ashpublications.org
The present study investigated the survival benefit of non–anthracycline (ANT)-based vs
ANT-based regimens in a large-scale, real-world cohort of patients with extranodal natural killer …

Risk‐based, response‐adapted therapy for early‐stage extranodal nasal‐type NK/T‐cell lymphoma in the modern chemotherapy era: a China Lymphoma …

…, X He, LL Zhang, G Wu, BL Qu, LT Qian… - American journal of …, 2020 - Wiley Online Library
We aimed to determine the survival benefits of chemotherapy (CT) added to radiotherapy (RT)
in different risk groups of patients with early‐stage extranodal nasal‐type NK/T‐cell …

[HTML][HTML] Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group …

…, Y Wang, X Liu, X He, LL Zhang, G Wu, BL Qu, LT Qian… - Leukemia, 2021 - nature.com
Limited evidence supports the use of early endpoints to evaluate the success of initial
treatment of extranodal NK/T-cell lymphoma (ENKTCL) in the modern era. We aim to analyze …

Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma

HH Ma, LT Qian, HF Pan, L Yang, HY Zhang… - Medical Oncology, 2010 - Springer
This study aims to investigate the prognostic factors and long-term treatment outcome in
patients with early stage nasal natural killer (NK)/T-cell lymphoma. Sixty-four patients were …

Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: a multicenter …

…, ZY Yuan, LL Zhang, G Wu, BL Qu, LT Qian… - Radiotherapy and …, 2018 - Elsevier
Purpose This study aimed to clarify the benefit of radiotherapy (RT) in patients with early-stage
extranodal NK/T-cell lymphoma (NKTCL) who achieve a complete response (CR) after …